BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17498561)

  • 21. Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myeloma.
    Stewart JP; Thompson A; Santra M; Barlogie B; Lappin TR; Shaughnessy J
    Br J Haematol; 2004 Jul; 126(1):72-6. PubMed ID: 15198734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients.
    Keats JJ; Maxwell CA; Taylor BJ; Hendzel MJ; Chesi M; Bergsagel PL; Larratt LM; Mant MJ; Reiman T; Belch AR; Pilarski LM
    Blood; 2005 May; 105(10):4060-9. PubMed ID: 15677557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential positioning and close spatial proximity of translocation-prone genes in nonmalignant B-cells from multiple myeloma patients.
    Martin LD; Harizanova J; Zhu G; Righolt CH; Belch AR; Mai S; Pilarski LM
    Genes Chromosomes Cancer; 2012 Aug; 51(8):727-42. PubMed ID: 22489023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression.
    Keats JJ; Reiman T; Maxwell CA; Taylor BJ; Larratt LM; Mant MJ; Belch AR; Pilarski LM
    Blood; 2003 Feb; 101(4):1520-9. PubMed ID: 12393535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma.
    Bergsagel PL; Kuehl WM
    Immunol Rev; 2003 Aug; 194():96-104. PubMed ID: 12846810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus.
    Våtsveen TK; Tian E; Kresse SH; Meza-Zepeda LA; Gabrea A; Glebov O; Dai HY; Sundan A; Kuehl WM; Børset M
    Leuk Res; 2009 Dec; 33(12):1670-7. PubMed ID: 19395026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma.
    Dring AM; Davies FE; Fenton JA; Roddam PL; Scott K; Gonzalez D; Rollinson S; Rawstron AC; Rees-Unwin KS; Li C; Munshi NC; Anderson KC; Morgan GJ
    Clin Cancer Res; 2004 Sep; 10(17):5692-701. PubMed ID: 15355895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis.
    Chang H; Li D; Zhuang L; Nie E; Bouman D; Stewart AK; Chun K
    Leuk Lymphoma; 2004 May; 45(5):965-9. PubMed ID: 15291356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MMSET: role and therapeutic opportunities in multiple myeloma.
    Xie Z; Chng WJ
    Biomed Res Int; 2014; 2014():636514. PubMed ID: 25093175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Nakazawa N; Taniwaki M; Yawata Y; Ueki A
    Int J Oncol; 1999 Dec; 15(6):1205-12. PubMed ID: 10568829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of IgH-MMSET fusion gene in multiple myeloma patients and its significance].
    Jiang H; Hou J; Chen YB; Ding SQ
    Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):515-8. PubMed ID: 14690579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FGFR3 dysregulation in multiple myeloma: frequency and prognostic relevance.
    Rasmussen T; Hudlebusch HR; Knudsen LM; Johnsen HE
    Br J Haematol; 2002 Jun; 117(3):626-8. PubMed ID: 12028033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.
    Tian E; Sawyer JR; Heuck CJ; Zhang Q; van Rhee F; Barlogie B; Epstein J
    Genes Chromosomes Cancer; 2014 Jul; 53(7):549-57. PubMed ID: 24638926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.
    Martinez-Garcia E; Popovic R; Min DJ; Sweet SM; Thomas PM; Zamdborg L; Heffner A; Will C; Lamy L; Staudt LM; Levens DL; Kelleher NL; Licht JD
    Blood; 2011 Jan; 117(1):211-20. PubMed ID: 20974671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations.
    Agnelli L; Bicciato S; Mattioli M; Fabris S; Intini D; Verdelli D; Baldini L; Morabito F; Callea V; Lombardi L; Neri A
    J Clin Oncol; 2005 Oct; 23(29):7296-306. PubMed ID: 16129847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.
    Chesi M; Kuehl WM; Bergsagel PL
    Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype.
    Rio-Machin A; Ferreira BI; Henry T; Gómez-López G; Agirre X; Alvarez S; Rodriguez-Perales S; Prosper F; Calasanz MJ; Martínez J; Fonseca R; Cigudosa JC
    Leukemia; 2013 Apr; 27(4):925-31. PubMed ID: 23174883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias.
    Sáez B; Martín-Subero JI; Odero MD; Prosper F; Cigudosa JC; Schoch R; Calasanz MJ; Siebert R
    Oncol Rep; 2007 Nov; 18(5):1099-106. PubMed ID: 17914559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment and characterization of a new human myeloma cell line, KYdelta-1, producing the delta/kappa type immunoglobulin.
    Ueda C; Yamada H; Akasaka T; Ohmori K; Sasada M; Uchiyama T; Ohno H
    Cancer Genet Cytogenet; 2001 Oct; 130(1):42-50. PubMed ID: 11672773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities.
    Rasmussen T; Theilgaard-Mönch K; Hudlebusch HR; Lodahl M; Johnsen HE; Dahl IM
    Br J Haematol; 2003 Oct; 123(2):253-62. PubMed ID: 14531906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.